Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02507193 · ClinicalTrials.gov registry record · NA
Fibular Fixation in Ankle Fractures:Plate Verses Nail.
A NA study, sponsored by Orlando Health.
- Completed
- Registry status
- NA
- Development phase
- 51
- Enrollment target
NCT02507193: Completed NA study, sponsored by Orlando Health.
NCT02507193 is a NA study that has completed, run by Orlando Health. The registered enrollment target is 51 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02507193, a NA study, has completed, sponsored by Orlando Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 51 participants
- Enrollment target
Study Summary
The primary objective of this study will be to evaluate the functional outcome of patients who present with a distal fibula fracture who were treated with either intermedullary nail (IMN) fixation or plate fixation.
Primary Outcome
The Olerud-Molander score is as assessment of symptoms after ankle fracture.
Interventions
- PROCEDURE Open reduction internal fixation
- PROCEDURE Intermedullary Nail
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 51 participants |
| Start Date | 2015-07 |
| Est. Completion | 2019-08-15 |
| Phase | NA |
What the finished NCT02507193 record still lists
NCT02507193 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 51 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).
The record links to 0 conditions, and to 2 interventions - of which Open reduction internal fixation is the first listed.
NCT02507193 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02507193 about?
NCT02507193 is a clinical study titled "Fibular Fixation in Ankle Fractures:Plate Verses Nail.". The primary objective of this study will be to evaluate the functional outcome of patients who present with a distal fibula fracture who were treated with either intermedullary nail (IMN) fixation or plate fixation.
What is the current status of trial NCT02507193?
This trial is currently completed. It is a NA study. The enrollment target is 51 participants. The study started on 2015-07. Estimated completion is 2019-08-15.
What interventions are being tested in trial NCT02507193?
The interventions under investigation include: Open reduction internal fixation (PROCEDURE), Intermedullary Nail (PROCEDURE).
Who is sponsoring clinical trial NCT02507193?
This trial is sponsored by Orlando Health, which has 21 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02507193's enrollment target sits among peer trials
51 1279th of 2000 higher than 722 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02701153 · 51 participants · NA
Phase II Study of 5-Day Hypofractionated Preoperative Radiation Therapy for Soft Tissue Sarcomas: Expansion Cohort
- NCT03663790 · 51 participants · NA
Effects of Gait Retraining on Lower Extremity Biomechanics
- NCT03874052 · 51 participants · Phase 1
Ruxolitinib in Combination With Venetoclax With and Without Azacitidine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
- NCT04704661 · 51 participants · Phase 1
Testing the Combination of Two Anti-cancer Drugs, DS-8201a and AZD6738, for The Treatment of Advanced Solid Tumors Expressing the HER2 Protein or Gene, The DASH Trial
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia